An active multidisciplinary interaction is an essential aspect which may improve outcomes in patients with lung cancer.
Physicians with relevant expertise are usually selected among members of the local hospital or community healthcare group.
An international discussion between two teams of different countries can impact the quality of patient-focused care, enhance collaboration between specialists and promote the tumour board efficiency.
Given the great interest in neoadjuvant and perioperative treatment in early disease, this year we decided to focus our attention on this setting, discussing 4 cases of limited/locally advanced disease.